Category B Biological Agent

A pathogen with a secondary level of surveillance interest as a biological weapon. Category B agents are moderately easy to disseminate; result in moderate morbidity rates and low mortality rates; and require specific enhancements of CDC's diagnostic capacity and enhanced disease surveillance
References in periodicals archive ?
The botulinum toxin test is one of several IGEN biological-agent detection tests based on the proprietary ORIGEN[R] technology, designed for the detection of Category A and Category B biological agents, including agents such as anthrax and Staphylococcus enterotoxin B, among others.
Government agencies using ORIGEN-based products for the detection of Category A and Category B biological agents, including agents such as anthrax, staphylococcus enterotoxin B, and botulinum toxin, among others.
During recent months IGEN has continued to work closely with numerous agencies within the military and departments of public health to use the Company's ORIGEN technology for the detection of Category A and Category B biological agents, including agents such as anthrax, staphylococcus enterotoxin B, and botulinum toxin, among others.